Published 11:34 IST, July 11th 2020
Gilead Sciences says remdesivir reduces risk of death in COVID-19 patients
Gilead's Remdesivir was associated with an improvement in clinical recovery and a 62 percent reduction in the risk of mortality compared with standard of care.
null | Image:
self
Advertisement
Loading...
11:34 IST, July 11th 2020